Tryptophan depletion in SSRI-recovered depressed outpatients

M. K. Spillmann, A. J W Van der Does, M. A. Rankin, R. D. Vuolo, Jonathan E. Alpert, A. A. Nierenberg, J. F. Rosenbaum, D. Hayden, D. Schoenfeld, M. Fava

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Rationale: Recently, a number of studies have challenged the finding that acute tryptophan depletion (TD) increases depressive symptoms in medicated, formerly depressed patients. The present study examined the effects of acute nutritional TD on remitted depressed patients currently treated with selective serotonin reup-take inhibitors. In an attempt to clarify conflicting earlier findings, the effects of a number of clinical variables on outcome were also investigated. Methods: Ten patients underwent TD in a double-blind, controlled, balanced crossover fashion. The control session followed the procedure of Krahn et al. (1996 Neuropsychopharmacology 15:325-328). Sessions were 5-8 days apart. Results: TD was significantly related to increased scores on clinician-rated depression and anxiety scales, and on self-rated depression, anxiety, and somatic symptoms. The control challenge had no effect, despite the fact that the reductions in plasma tryptophan during the control session were unexpectedly high. Some evidence was found for a threshold in the relationship between reduction of plasma tryptophan and mood response. Conclusions: The mood effect of TD in medicated, formerly depressed patients was confirmed. A threshold may exist for mood effects following TD, implying that recent negative findings may have been caused by insufficient depletion. No other predicting or mediating factors were identified, although the variable "history of response pattern to medication" deserves further study.

Original languageEnglish (US)
Pages (from-to)123-127
Number of pages5
JournalPsychopharmacology
Volume155
Issue number2
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Tryptophan
Outpatients
Depression
Anxiety
Serotonin

Keywords

  • Depression Antidepressant
  • Mood effect
  • Remission
  • Tryptophan depletion

ASJC Scopus subject areas

  • Pharmacology

Cite this

Spillmann, M. K., Van der Does, A. J. W., Rankin, M. A., Vuolo, R. D., Alpert, J. E., Nierenberg, A. A., ... Fava, M. (2001). Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology, 155(2), 123-127. https://doi.org/10.1007/s002130000669

Tryptophan depletion in SSRI-recovered depressed outpatients. / Spillmann, M. K.; Van der Does, A. J W; Rankin, M. A.; Vuolo, R. D.; Alpert, Jonathan E.; Nierenberg, A. A.; Rosenbaum, J. F.; Hayden, D.; Schoenfeld, D.; Fava, M.

In: Psychopharmacology, Vol. 155, No. 2, 2001, p. 123-127.

Research output: Contribution to journalArticle

Spillmann, MK, Van der Does, AJW, Rankin, MA, Vuolo, RD, Alpert, JE, Nierenberg, AA, Rosenbaum, JF, Hayden, D, Schoenfeld, D & Fava, M 2001, 'Tryptophan depletion in SSRI-recovered depressed outpatients', Psychopharmacology, vol. 155, no. 2, pp. 123-127. https://doi.org/10.1007/s002130000669
Spillmann MK, Van der Does AJW, Rankin MA, Vuolo RD, Alpert JE, Nierenberg AA et al. Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology. 2001;155(2):123-127. https://doi.org/10.1007/s002130000669
Spillmann, M. K. ; Van der Does, A. J W ; Rankin, M. A. ; Vuolo, R. D. ; Alpert, Jonathan E. ; Nierenberg, A. A. ; Rosenbaum, J. F. ; Hayden, D. ; Schoenfeld, D. ; Fava, M. / Tryptophan depletion in SSRI-recovered depressed outpatients. In: Psychopharmacology. 2001 ; Vol. 155, No. 2. pp. 123-127.
@article{e3257caddd5d43b4ac93c3e641f94915,
title = "Tryptophan depletion in SSRI-recovered depressed outpatients",
abstract = "Rationale: Recently, a number of studies have challenged the finding that acute tryptophan depletion (TD) increases depressive symptoms in medicated, formerly depressed patients. The present study examined the effects of acute nutritional TD on remitted depressed patients currently treated with selective serotonin reup-take inhibitors. In an attempt to clarify conflicting earlier findings, the effects of a number of clinical variables on outcome were also investigated. Methods: Ten patients underwent TD in a double-blind, controlled, balanced crossover fashion. The control session followed the procedure of Krahn et al. (1996 Neuropsychopharmacology 15:325-328). Sessions were 5-8 days apart. Results: TD was significantly related to increased scores on clinician-rated depression and anxiety scales, and on self-rated depression, anxiety, and somatic symptoms. The control challenge had no effect, despite the fact that the reductions in plasma tryptophan during the control session were unexpectedly high. Some evidence was found for a threshold in the relationship between reduction of plasma tryptophan and mood response. Conclusions: The mood effect of TD in medicated, formerly depressed patients was confirmed. A threshold may exist for mood effects following TD, implying that recent negative findings may have been caused by insufficient depletion. No other predicting or mediating factors were identified, although the variable {"}history of response pattern to medication{"} deserves further study.",
keywords = "Depression Antidepressant, Mood effect, Remission, Tryptophan depletion",
author = "Spillmann, {M. K.} and {Van der Does}, {A. J W} and Rankin, {M. A.} and Vuolo, {R. D.} and Alpert, {Jonathan E.} and Nierenberg, {A. A.} and Rosenbaum, {J. F.} and D. Hayden and D. Schoenfeld and M. Fava",
year = "2001",
doi = "10.1007/s002130000669",
language = "English (US)",
volume = "155",
pages = "123--127",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Tryptophan depletion in SSRI-recovered depressed outpatients

AU - Spillmann, M. K.

AU - Van der Does, A. J W

AU - Rankin, M. A.

AU - Vuolo, R. D.

AU - Alpert, Jonathan E.

AU - Nierenberg, A. A.

AU - Rosenbaum, J. F.

AU - Hayden, D.

AU - Schoenfeld, D.

AU - Fava, M.

PY - 2001

Y1 - 2001

N2 - Rationale: Recently, a number of studies have challenged the finding that acute tryptophan depletion (TD) increases depressive symptoms in medicated, formerly depressed patients. The present study examined the effects of acute nutritional TD on remitted depressed patients currently treated with selective serotonin reup-take inhibitors. In an attempt to clarify conflicting earlier findings, the effects of a number of clinical variables on outcome were also investigated. Methods: Ten patients underwent TD in a double-blind, controlled, balanced crossover fashion. The control session followed the procedure of Krahn et al. (1996 Neuropsychopharmacology 15:325-328). Sessions were 5-8 days apart. Results: TD was significantly related to increased scores on clinician-rated depression and anxiety scales, and on self-rated depression, anxiety, and somatic symptoms. The control challenge had no effect, despite the fact that the reductions in plasma tryptophan during the control session were unexpectedly high. Some evidence was found for a threshold in the relationship between reduction of plasma tryptophan and mood response. Conclusions: The mood effect of TD in medicated, formerly depressed patients was confirmed. A threshold may exist for mood effects following TD, implying that recent negative findings may have been caused by insufficient depletion. No other predicting or mediating factors were identified, although the variable "history of response pattern to medication" deserves further study.

AB - Rationale: Recently, a number of studies have challenged the finding that acute tryptophan depletion (TD) increases depressive symptoms in medicated, formerly depressed patients. The present study examined the effects of acute nutritional TD on remitted depressed patients currently treated with selective serotonin reup-take inhibitors. In an attempt to clarify conflicting earlier findings, the effects of a number of clinical variables on outcome were also investigated. Methods: Ten patients underwent TD in a double-blind, controlled, balanced crossover fashion. The control session followed the procedure of Krahn et al. (1996 Neuropsychopharmacology 15:325-328). Sessions were 5-8 days apart. Results: TD was significantly related to increased scores on clinician-rated depression and anxiety scales, and on self-rated depression, anxiety, and somatic symptoms. The control challenge had no effect, despite the fact that the reductions in plasma tryptophan during the control session were unexpectedly high. Some evidence was found for a threshold in the relationship between reduction of plasma tryptophan and mood response. Conclusions: The mood effect of TD in medicated, formerly depressed patients was confirmed. A threshold may exist for mood effects following TD, implying that recent negative findings may have been caused by insufficient depletion. No other predicting or mediating factors were identified, although the variable "history of response pattern to medication" deserves further study.

KW - Depression Antidepressant

KW - Mood effect

KW - Remission

KW - Tryptophan depletion

UR - http://www.scopus.com/inward/record.url?scp=0035023028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035023028&partnerID=8YFLogxK

U2 - 10.1007/s002130000669

DO - 10.1007/s002130000669

M3 - Article

C2 - 11400999

AN - SCOPUS:0035023028

VL - 155

SP - 123

EP - 127

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 2

ER -